Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences

Figure 5

Triple expression of NeuGcGM3, EGFR, and EGF in lung adenocarcinoma. (a) Hematoxylin and eosin staining. ((b)–(d)) High levels of NeuGcGM3, EGFR, and EGF expression, respectively (brown color). Counterstaining with Mayer’s Hematoxylin (blue color). White bar = 100 μm.

(a)

(b)

(c)

(d)